Position in PFE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$554,086,668
-$229,178,025 QoQ
Shares Held
23,010,244
-17.5% QoQ
Ownership
0.404%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#25
of 2,812 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 52%
Shared 0%
None 48%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $61,093,076,744 across 19 Drug Manufacturers - General names. PFE ranks #9 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
12,598,524 | $15,111,048,894 | |
| 2 | JNJ |
Johnson & Johnson
|
58,301,609 | $14,806,859,626 | |
| 3 | ABBV |
AbbVie Inc.
|
47,862,796 | $12,044,193,975 | |
| 4 | MRK |
Merck & Co., Inc.
|
43,886,420 | $5,639,404,964 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
71,713,442 | $4,132,128,518 | |
| 6 | AZN |
Astrazeneca PLC
|
19,204,823 | $3,641,618,528 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
20,820,621 | $2,630,477,247 | |
| 8 | AMGN |
Amgen Inc
|
3,588,484 | $1,299,461,817 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $554,086,668 | 23,010,244 | Shares | Other | 2026-08-12 | |
| 2026-03-31 | $783,264,693 | 27,894,042 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $581,202,021 | 23,341,447 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $720,149,946 | 28,263,342 | Shares | Other | 2025-11-07 | |
| 2025-06-30 | $711,651,754 | 29,358,571 | Shares | Other | 2025-08-12 | |
| 2025-03-31 | $817,586,424 | 32,264,658 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $719,510,862 | 27,120,651 | Shares | Other | 2025-02-12 | |
| 2024-09-30 | $1,088,994,045 | 37,629,373 | Shares | Sole | 2024-12-26 | |
| 2024-06-30 | $1,081,848,005 | 38,665,047 | Shares | Other | 2024-12-26 | |
| 2024-03-31 | $1,157,739,511 | 41,720,343 | Shares | Other | 2024-12-26 | |
| 2023-12-31 | $1,249,352,288 | 43,395,356 | Shares | Other | 2024-12-26 | |
| 2023-09-30 | $1,375,370,257 | 41,464,283 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,576,379,368 | 42,976,537 | Shares | Other | 2023-08-11 | |
| 2023-03-31 | $1,457,775,506 | 35,729,792 | Shares | Sole | 2023-05-18 | |
| 2022-12-31 | $2,516,410,431 | 49,110,274 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $1,727,604,795 | 39,479,086 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $2,151,306,437 | 41,031,975 | Shares | Other | 2022-08-11 | |
| 2022-03-31 | $1,711,015,316 | 33,050,325 | Shares | Other | 2022-05-11 | |
| 2021-12-31 | $1,780,956,673 | 30,160,147 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $1,024,301,766 | 23,815,433 | Shares | Other | 2021-11-12 | |
| 2021-06-30 | $1,238,775,723 | 31,633,701 | Shares | Other | 2021-08-12 | |
| 2021-03-31 | $1,279,103,472 | 35,305,092 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $1,291,988,329 | 35,098,841 | Shares | Other | 2021-02-19 | |
| 2020-09-30 | $1,327,495,263 | 36,171,569 | Shares | Other | 2020-11-12 | |
| 2020-06-30 | $1,317,068,574 | 40,277,285 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $1,774,818,476 | 54,375,640 | Shares | Other | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||